263 related articles for article (PubMed ID: 9377957)
1. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
Ofiara L; Roman T; Schwartzman K; Levy RD
Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
[TBL] [Abstract][Full Text] [Related]
2. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
3. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.
Hernandez P; Gursahaney A; Roman T; Schwartzman K; Donath D; Cosio MG; Levy RD
Thorax; 1996 Apr; 51(4):354-8. PubMed ID: 8733484
[TBL] [Abstract][Full Text] [Related]
4. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
[TBL] [Abstract][Full Text] [Related]
5. [Brachytherapy in the treatment of lung and tracheal cancer: current indications, methods, results].
Skowronek J; Młynarczyk W; Piorunek T
Przegl Lek; 2006; 63(8):664-73. PubMed ID: 17441380
[TBL] [Abstract][Full Text] [Related]
6. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
7. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron.
Burt PA; O'Driscoll BR; Notley HM; Barber PV; Stout R
Thorax; 1990 Oct; 45(10):765-8. PubMed ID: 1701061
[TBL] [Abstract][Full Text] [Related]
8. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
9. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients.
Gollins SW; Burt PA; Barber PV; Stout R
Radiother Oncol; 1994 Oct; 33(1):31-40. PubMed ID: 7533304
[TBL] [Abstract][Full Text] [Related]
10. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
11. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
12. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma.
Bedwinek J; Petty A; Bruton C; Sofield J; Lee L
Int J Radiat Oncol Biol Phys; 1992; 22(1):23-30. PubMed ID: 1727125
[TBL] [Abstract][Full Text] [Related]
13. Endobronchial brachytherapy in combination with external beam irradiation in obstructing malignant bronchial tumors.
Prévost A; Berthiot G; Picavet B; Froissart D; Loirette M; Costa B; Cauchois A; Nguyen TD
Oncol Rep; 2003; 10(4):921-5. PubMed ID: 12792746
[TBL] [Abstract][Full Text] [Related]
14. Physiological effect of endobronchial radiotherapy in patients with major airway occlusion by carcinoma.
Goldman JM; Bulman AS; Rathmell AJ; Carey BM; Muers MF; Joslin CA
Thorax; 1993 Feb; 48(2):110-4. PubMed ID: 8388128
[TBL] [Abstract][Full Text] [Related]
15. Endobronchial brachytherapy.
Villanueva AG; Lo TC; Beamis JF
Clin Chest Med; 1995 Sep; 16(3):445-54. PubMed ID: 8521699
[TBL] [Abstract][Full Text] [Related]
16. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A
Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550
[TBL] [Abstract][Full Text] [Related]
17. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
Mallick I; Sharma SC; Behera D
Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
[TBL] [Abstract][Full Text] [Related]
20. Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma.
Tomberlin JK; Halperin EC; Kusin P; Leopold K; Bentel G; George S; Powers M; Wolfe W
J Surg Oncol; 1992 Apr; 49(4):213-9. PubMed ID: 1556864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
